Catalent 
Welcome,         Profile    Billing    Logout  
 3 Products   238 Diseases  3 Products   2 Trials   75 News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chronodyne (terbutaline vaginal gel) / Ardana Biosci, Catalent
Endometriosis & Endometrial Pain-5: Phase II studies of Chronodyne

Not yet recruiting
2
0
RoW
Chronodyne (terbutaline vaginal gel)
Columbia
Endometriosis & Endometrial Pain
 
 
progesterone intravaginal ring (JNP-0301) / Catalent
NCT06668896: Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert

Not yet recruiting
1
60
NA
Progesterone
Daré Bioscience, Inc., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Pre Term Birth
01/26
06/26
estrogen/progesterone intravaginal ring (DARE-HRT1) / Daré Biosci
DARE-HRT1, NCT05367973: Study of Over 12 Weeks in Healthy PostMenopausal Women

Completed
1/2
21
RoW
IVR Dose 1, IVR Dose 2
Daré Bioscience, Inc.
Vulvovaginal Atrophy, Vasomotor Symptoms
01/23
03/23
oxybutinin intravaginal ring (JNP-0101) / Catalent
No trials found
TRPH-222 / Triphase Accelerator Corporation, BMS
No trials found
ENU200 / Ennaid Therap, Catalent
No trials found
virus-like protein based coronavirus vaccine / Spicona, Catalent
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chronodyne (terbutaline vaginal gel) / Ardana Biosci, Catalent
Endometriosis & Endometrial Pain-5: Phase II studies of Chronodyne

Not yet recruiting
2
0
RoW
Chronodyne (terbutaline vaginal gel)
Columbia
Endometriosis & Endometrial Pain
 
 
progesterone intravaginal ring (JNP-0301) / Catalent
NCT06668896: Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert

Not yet recruiting
1
60
NA
Progesterone
Daré Bioscience, Inc., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Pre Term Birth
01/26
06/26
estrogen/progesterone intravaginal ring (DARE-HRT1) / Daré Biosci
DARE-HRT1, NCT05367973: Study of Over 12 Weeks in Healthy PostMenopausal Women

Completed
1/2
21
RoW
IVR Dose 1, IVR Dose 2
Daré Bioscience, Inc.
Vulvovaginal Atrophy, Vasomotor Symptoms
01/23
03/23
oxybutinin intravaginal ring (JNP-0101) / Catalent
No trials found
TRPH-222 / Triphase Accelerator Corporation, BMS
No trials found
ENU200 / Ennaid Therap, Catalent
No trials found
virus-like protein based coronavirus vaccine / Spicona, Catalent
No trials found

Download Options